Stocks and Investing
Stocks and Investing
Fri, August 2, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, August 1, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matthew Kaplan Upgraded (UTHR) to Strong Buy and Increased Target to $106 on, Aug 1st, 2019
Matthew Kaplan of Ladenburg Thalmann, Upgraded "United Therapeutics Corporation" (UTHR) to Strong Buy and Increased Target from $103 to $106 on, Aug 1st, 2019.
Matthew has made no other calls on UTHR in the last 4 months.
There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Martin Auster of "UBS" Upgraded from Strong Sell to Hold and Decreased Target to $94 on, Friday, May 17th, 2019
These are the ratings of the 2 analyists that currently disagree with Matthew
- M. Auster of "Credit Suisse" Upgraded from Hold to Buy on, Monday, July 1st, 2019
- Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $273 on, Thursday, May 2nd, 2019
Contributing Sources